In the detection of serum samples, the positive rates of CEA and CA125 in the malignant group were higher than those in the benign group, which again confirmed the high expression of CEA and CA125 in NSCLC patients combined with malignant pleural effusion. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.